## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: PEG 6.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($406.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Synopsys Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Synopsys, Inc. - SNPS**
- Source: KXAN Austin | 20251201T220800 | Neutral | Relevance: 99%
- ClaimsFiler is reminding investors who suffered losses exceeding $100,000 in Synopsys, Inc. (NasdaqGS: SNPS) to file lead plaintiff applications by December 30, 2025, in ongoing class action lawsuits. The lawsuits allege that Synopsys and its executives failed to disclose material information, leading to a significant stock price drop after the company reported disappointing Q3 2025 financial results. Investors who purchased securities between December 4, 2024, and September 9, 2025, or acquired Synopsys stock from an Ansys acquisition, may be affected.

**2. Synopsys Just Got A $2 Billion Boost From NVIDIA â€” Here's What Investors Should Know**
- Source: Benzinga | 20251201T104500 | Bullish | Relevance: 99%
- NVIDIA has invested $2 billion in Synopsys common stock at $414.79 per share to expand their partnership in advanced computing and engineering tools. This collaboration aims to integrate NVIDIA's GPU computing with Synopsys' simulation and digital-twin technologies to accelerate innovation and ease development bottlenecks in complex design cycles across various industries. The partnership will focus on integrating AI tools, advancing digital twins using NVIDIA's Omniverse and Cosmos platforms, and making GPU-accelerated engineering tools available through cloud platforms.

**3. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys**
- Source: Markets Financial Content | 20251129T133400 | Neutral | Relevance: 99%
- Faruqi & Faruqi, LLP is investigating potential claims against Synopsys, Inc. on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The investigation follows a federal securities class action alleging that Synopsys made misleading statements regarding its business operations, particularly concerning its Design IP business and the impact of increased focus on AI customers. This alert comes after Synopsys's stock price fell significantly following disappointing third-quarter 2025 financial results and revised guidance.

**4. SNPS DEADLINE: Faruqi & Faruqi Reminds Synopsys Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 30, 2025 - SNPS**
- Source: PR Newswire | 20251130T141800 | Neutral | Relevance: 99%
- Faruqi & Faruqi, LLP reminds investors of Synopsys, Inc. (NASDAQ: SNPS) about a pending class action lawsuit with a lead plaintiff deadline of December 30, 2025. The lawsuit alleges that Synopsys and its executives made false and misleading statements regarding the impact of increased AI customer focus on its Design IP business, leading to material negative financial results. Synopsys's stock price fell significantly after revealing its "IP business underperformed expectations" in Q3 2025, missing revenue guidance and reporting a year-over-year decline in net income and Design IP segment revenue.

**5. 23,800 Shares in Synopsys, Inc. $SNPS Purchased by BLI Banque de Luxembourg Investments**
- Source: MarketBeat | 20251130T085529 | Neutral | Relevance: 99%
- BLI Banque de Luxembourg Investments recently purchased 23,800 shares of Synopsys, Inc. (NASDAQ:SNPS) for approximately $11.96 million. This article details additional institutional buying and selling, analyst ratings, and insider transactions related to Synopsys. Key financial metrics and recent earnings performance are also provided.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Rosenblatt | $560 | $605 | -7% |
| 2025-12-08 | B of A Securiti | $500 | $525 | -5% |
| 2025-12-03 | Keybanc | $575 | $590 | -3% |
| 2025-11-25 | Wells Fargo | $445 | $550 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Rosenblatt | up | Buy |
| 2025-12-08 | B of A Securiti | up | Neutral |
| 2025-12-03 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.54M) |
| Sells | 3 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.1x requires aggressive growth execution.
2. Long-term trend broken: trading 10.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +7.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 6.11 signals overvaluation risk, limited margin of safety. Forward P/E 31.2x stretched relative to 9% growth. Quality metrics strong (margin 31%). Revenue growth strong at 37% YoY. Analyst sentiment negative (4 target cuts vs 0 raises). Insider buying signal ($0.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $90.7B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.11 |
| Forward P/E | 31.2 |
| Current P/E | 34.1 |
| YoY Growth | 9.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.1% to 7.8% (+7.8% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 96th percentile. MRS_5 at 5.2% confirms short-term momentum alignment. AM_20 at 8.9% shows strong absolute momentum above own 20MA. Outperforming sector by 8.9pp, stock-specific strength. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (7.07), confirming momentum. RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.84% (CS: 97) | Strong |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 7.07 | Bullish |
| vs SMA20 | 1.089x | Above |
| vs SMA50 | 0.994x | Below |
| vs SMA200 | 0.896x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $438.29
- **Stop Loss:** $406.13 (7.3% risk)
- **Target:** $470.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 37
- **Position Value:** $16,216.73
- **Portfolio %:** 16.22%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |
| 2024Q4 | $3.30 | $3.40 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*